| · Understanding how prioritizing patient care enhances trial success
· FDA guidance driving patient-centric clinical development · Real-world impact of patient input on protocol design and trial conduct |
Archives: Agenda
How to Choose the Right Clinical CRO: A Strategic Guide for Biotech Venture
| · Determining the optimal stage for CRO engagement to maximize efficiency
· Engaging CROs in protocol development to inform strategic decisions, including country selection and trial design considerations · Leveraging CRO expertise by fostering a collaborative, partnership-driven relationship |
Exploring New Frontiers in Radiopharma: Global Strategies for Clinical Success
• Following recent shifts in the FDA landscape, radiophama developers are increasingly exploring alternative regions and pathways to advance early-stage programs more efficiently
• Global interest in radiopharma including Korea’s rapidly growing focus, reflects a strategic move toward more flexible, collaborative, and regionally diversified development models
• Novotech’s multi-country radiopharma studies demonstrate an agile and integrated approach, showing how a CRO can deliver end-to-end support from preclinical planning to late-phase execution
Chairperson’s opening remarks
Registration and refreshments
Unlocking FDA Strategies for Speedy Approval and Smart Dosing in Oncology Trials
- Exploring recent US FDA updates on expedited approval pathways and dosing strategies in oncology
- Designing clinical trials that meet FDA expectations for surrogate endpoints and biomarker use
- Developing regulatory-aligned strategies for oncology drug development under new FDA guidance
END OF CONFERENCE
Chairperson’s closing remarks
Chairperson’s closing remarks
Lunch and networking
Prize Draw taking place in exhibition hall at 14:15
Join us for a chance to win one of our prizes, including Apple products